Sio Gene Therapies Inc. logo

Sio Gene Therapies Inc.

NASDAQ:SIOX

Overview | Financials
Company Name Sio Gene Therapies Inc.
Symbol SIOX
Currency USD
Price 0.415
Market Cap 30,699,708
Dividend Yield 91%
52-week-range 0.415 - 0.415
Industry Biotechnology
Sector Healthcare
CEO Mr. David W. Nassif J.D.
Website https://www.siogtx.com

An error occurred while fetching data.

About Sio Gene Therapies Inc.

Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to

Related Stocks

Landos Biopharma, Inc. logo

Landos Biopharma, Inc.

LABP

22.93 USD

Onconova Therapeutics, Inc. logo

Onconova Therapeutics, Inc.

ONTX

0.995 USD

Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc.

ABEO

5.55 USD

Aytu BioPharma, Inc. logo

Aytu BioPharma, Inc.

AYTU

2.39 USD

Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc.

CLRB

2.08 USD

Ekso Bionics Holdings, Inc. logo

Ekso Bionics Holdings, Inc.

EKSO

1.15 USD

Financials

Numbers are in millions USD

Numbers are in millions USD